Treating the chemically dependent health professional.

Treating the chemically dependent health professional. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treating the chemically dependent health professional. Abstract Text:

Chemical dependence among health professionals is a significant problem, with a lifetime prevalence of approximately 10-15%. A physician who undertakes the challenge of treating other physicians for chemical dependence must have firm boundaries, and must be willing to provide extra time and patience. Denial of symptoms, countertransference and other pitfalls have been cited as prominent potential problems. Although there is evidence that physicians in general have excellent outcomes following chemical dependence treatment, mismanagement can be disastrous. Standards are suggested for centers that wish to treat this population.

Treating the chemically dependent health professional. Publishing Authors By Initials

For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

PUBMED ID PMID:

MEDLINE DATE:

Treating the chemically dependent health professional. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of addictive diseases

VOLUME: 16

Page Numbers: 67-73

Journal Abbreviation:

ISSN: 1055-0887

DAY: 12

MONTH: 05

YEAR: 1997

Treating the chemically dependent health professional. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9107051

Treating the chemically dependent health professional. Keywords Mesh Terms:

KEYWORDS: Substance-Related Disorders

MESH TERMS: therapy

Chemical & Substance for Abstract: Treating the chemically dependent health professional. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treating the chemically dependent health professional.

AFFILIATION: Department of Medicine, Oregon Health Sciences University, Newberg 97132, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Addict Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treating the chemically dependent health professional Related Publications

• A conceptual model for the study of the health action process.
• Carbamates in the chemotherapy of leukemia; observation of a possible antileukemic synergism between urethane and methyl-bis (beta-chloroethyl) amine.
• Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774).
• Combination therapy: some concepts and results.
• Decentralized medical education in rural communities: the circuit rider connection.
• Dietary intake and parents' perception of mealtime behaviors in preschool-age children with autism spectrum disorder and in typically developing children.
• Drug evaluation in experimental tumor systems: potential and limitations in 1961.
• Experimental adjuvant chemotherapy: an overview.
• Experimental clinical cancer chemotherapy. Philosophy at the preclinical level.
• Formation of giant solvation shells around fulleride anions in liquid ammonia.
• HYPOTHYROIDISM IN DIABETICS TREATED WITH SULPHONYLUREA.
• Homelessness and substance use among alcohol abusers following participation in project H&ART.
• Identification of Adducts Formed by Reaction of N-Acetoxy-3,5-dimethylaniline with DNA.
• Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins.
• Integration of continuous-flow accelerator mass spectrometry with chromatography and mass-selective detection.
• Observations of the retiring chairman of the Cancer Chemotherapy Review Board.
• Observations on the antileukemic activity of pyridine-2-carboxaldehyde thiosemicarbazone and thiocarbohydrazone.
• Physician behavior modification using claims data: tetracycline for upper respiratory infection.
• Proceedings: Successes and failures at the preclinical level; where now?
• Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.
• Steerable real-time sonographically guided needle biopsy.
• Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster.
• Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755.
• The "sensitivity" of resting and dividing cells.
• Treating the chemically dependent health professional.